Pernicious Anemia

Last updated: February 8, 2026Reviewed date: February 8, 2026Reading time: 15 min read
Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Pernicious anemia is a rare blood disorder characterized by the inability of the body to properly utilize vitamin B12, from a deficiency of cobalamin (vitamin B12), which in turn is caused by a lack of intrinsic factors (IF) that are essential for the development of...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Pernicious anemia is a rare blood disorder characterized by the inability of the body to properly utilize vitamin B12, from a deficiency of cobalamin (vitamin B12), which in turn is caused by a lack of intrinsic factors (IF) that are essential for the development of red blood cells. An intrinsic factor is a glycoprotein that binds cobalamin and thereby enables its absorption in the terminal...

Key Takeaways

  • This article explains Symptoms in simple medical language.
  • This article explains Causes in simple medical language.
  • This article explains Diagnosis in simple medical language.
  • This article explains Treatment in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Fever with very low white blood cells or known immune suppression.
  • Unusual bruising, persistent bleeding, black stools, or severe weakness.
  • Shortness of breath, fainting, confusion, or rapidly worsening fatigue.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

Pernicious anemia is a rare blood disorder characterized by the inability of the body to properly utilize vitamin B12, from a deficiency of cobalamin (vitamin B12), which in turn is caused by a lack of intrinsic factors (IF) that are essential for the development of red blood cells. An intrinsic factor is a glycoprotein that binds cobalamin and thereby enables its absorption in the terminal ileum. Pernicious anemia is often described as an autoimmune disorder due to the findings of gastric autoantibodies directed against both IF and parietal cells and the increased frequency of other autoimmune diseases seen in patients with pernicious anemia. Most cases result from the lack of gastric protein known as intrinsic factor, without which vitamin B12 cannot be absorbed.

The symptoms of pernicious anemia may include weakness, fatigue, an upset stomach, an abnormally rapid heartbeat (tachycardia), and/or chest pains. Recurring episodes of anemia (megaloblastic) and an abnormal yellow coloration of the skin (jaundice) are also common. Pernicious anemia is thought to be an autoimmune disorder, and certain people may have a genetic predisposition to this disorder.

There is a rare congenital form of pernicious anemia in which babies are born lacking the ability to produce effective intrinsic factors. There is also a juvenile form of the disease, but pernicious anemia typically does not appear before the age of 30. The onset of the disease is slow and may span decades. When the disease goes undiagnosed and untreated for a long period of time, it may lead to neurological complications. Nerve cells and blood cells need vitamin B12 to function properly.

Symptoms

Symptoms of pernicious anemia may include fatigue, shortness of breath, rapid heart rate, jaundice or pallor, tingling and numbness of hands and feet, loss of appetite, diarrhea, unsteadiness when walking, bleeding gums, impaired sense of smell, and confusion. Symptoms may include fatigue, pallor, paresthesia, incontinence, psychosis, and generalized weakness.

The symptoms of juvenile pernicious anemia are usually obvious between the ages of 4 and 28 months. Most affected infants develop a form of anemia known as megaloblastic anemia. Large, immature red blood cells are found in the blood (megaloblasts), impairing the ability of the blood to deliver oxygen to the tissues of the body. Other types of blood cells (e.g., platelets and white blood cells) may also be deficient (pancytopenia). Symptoms may include vomiting, diarrhea, fatigue, pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">headache, inability to sleep (insomnia), lack of appetite, failure to thrive, yellow coloration of the skin (jaundice), irritability, and/or a pale complexion. Mental retardation is also common in infants with juvenile pernicious anemia. Affected infants may experience repeated episodes of extreme anemia and jaundice. Some children with the juvenile form of the disease have blood protein present in their urine (persistent proteinuria) and some may have urinary tract malformations.

Individuals with congenital pernicious anemia present with symptoms very similar to the juvenile form. These however progress comparatively slowly; so slowly that the signs of neurological deficits may precede those associated with the decline in blood capacity. The symptoms may include generalized weakness and fatigue, difficulty breathing (dyspnea), an abnormally rapid heartbeat (tachycardia), and/or chest pains (angina). Affected individuals may also have gastrointestinal problems, such as a profound lack of appetite (anorexia), abdominal pain, indigestion, belching, and/or constipation and diarrhea. Weight loss is also common. Some people with Pernicious Anemia may have an abnormally enlarged liver (hepatomegaly) or spleen (splenomegaly). Other problems involving urinary function may also develop.

Because nerve cells need vitamin B12 to function properly, some people with pernicious anemia will display neurological symptoms. Nerves other than those of the brain and spinal cord (peripheral nervous system) are frequently affected. Occasionally, the spinal cord may also be involved. Neurological symptoms may include numbness, tingling, loss of sensation in the arms and/or legs (acroparesthesias). Other neurological symptoms may include impaired ability to coordinate movement (ataxia), a positive Babinski sign (outward motion of the big toe caused by stroking the sole of the foot), and/or exaggerated reflexes (hyperreflexia). Some people with pernicious anemia may also become extremely irritable or depressed and, in some rare cases, even experience paranoia (megaloblastic madness).

Causes

Pernicious anemia is thought to be an autoimmune disease. Autoimmune disorders are caused when the body’s natural defenses (e.g., antibodies) against “foreign” or invading organisms begin to attack healthy tissue for unknown reasons. Pernicious anemia is sometimes seen in association with certain autoimmune endocrine diseases, such as type 1 diabetes, hypoparathyroidism, Addison’s disease, and Graves’ disease.

However, since the disorder also tends to occur with greater frequency in certain families than in others, it is also believed that there may be a genetic component to pernicious anemia. In general, risk factors for pernicious anemia include a family history of the disease, being of Northern European or Scandinavian descent, and a history of autoimmune endocrine disorders.

The congenital and juvenile forms are thought to be inherited as autosomal recessive traits. The gene responsible for anemia due to intrinsic factor deficiency has been tracked to a location on chromosome 11 (11q13). The gene responsible for anemia due to the intestinal malabsorption of vitamin B12 has been tracked to sites on chromosomes 14 (14q32) and 10 (10p12.1).

Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated “p” and a long arm designated “q”. Chromosomes are further sub-divided into many bands that are numbered. For example, “chromosome 11q13” refers to band 13 on the long arm of chromosome 11. Similarly, gene map loci 14q32 and 10p12.1 refer to a site at band 32 on the long arm of chromosome 14, and at band 12.1 on the short arm of chromosome 10. The numbered bands specify the location of the thousands of genes that are present on each chromosome.

Genetic diseases are determined by the combination of genes for a particular trait that is on the chromosomes received from the father and the mother.

Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier of the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.

All individuals carry a few abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.

Autoimmune

Autoimmune gastritis is characterized by the destruction of gastric parietal cells and the resulting lack of the glycoprotein intrinsic factor secreted by these cells. The antibodies identified with autoimmunity are intrinsic factor antibodies (IFA) and parietal cell antibodies (PCA).

Parietal cell antibodies work against the parietal cell proton pump ATPase. The primary targets of parietal cell antibodies are the alpha and beta proton pump subunits. Research has determined that parietal cell antibodies are immunoglobulins from the M, G, and A isotypes, which operate against both subunits.

Intrinsic factor antibodies are immunoglobulin G isotype, and they can be either type 1 or type 2 antibodies. Type 1 conducts against the cobalamin binding site. Type 2 acts against the ileal mucosa receptor.

Other autoimmune diseases include pernicious anemia, which can be associated with autoimmune diseases, such as type 1 diabetes (3% to 4%), vitiligo (2% to 8%), and autoimmune thyroid disease (3% to 32%). This association has led to studies exposing that HLA alleles may be related to autoimmune gastritis. HLA-DRB1/03 and HLA-DRB1/04 alleles may predispose to autoimmune gastritis.

Genetic

Researchers have also identified congenital and juvenile forms of pernicious anemia, which are thought to follow an autosomal recessive inheritance pattern.

Other causes of cobalamin deficiency include:

  • Vegetarian diet
  • Loss of gastric mucosa (gastrectomy, use of H2 blockers)
  • Insufficient pancreatic enzymes (ZES, chronic pancreatitis)
  • Tapeworm infestation
  • Bacterial overgrowth
  • Defects in the ileal mucosa leading to poor uptake of cobalamin

Diagnosis

The diagnosis of pernicious anemia may be confirmed by a thorough clinical evaluation, including detailed patient history and specialized laboratory tests. During a Schilling test, the intestines’ ability to absorb vitamin B12 is measured. The vitamin is labeled with radioactive cobalt and is ingested by mouth. X-ray studies can then determine if the body is properly absorbing this vitamin.

The clinician should also conduct a complete physical exam emphasizing hematological, gastrointestinal, and neurological findings.

  • Hematological manifestations: pallor, fatigue, shortness of breath, dizziness, tachycardia, lightheadedness, and decreased cognitive and physical function
  • Gastrointestinal manifestations: abdominal bloating, loss of appetite, weight loss, and diarrhea
  • Neurological manifestations: Peripheral neuropathy, paresthesia, weakness, ataxia, forgetfulness, and psychosis
  • Cardiac symptoms may include dyspnea, palpitations, and edema.
  • Urinary retention as a result of spinal cord damage can also occur.

Pernicious anemia, if left untreated, may be fatal. The physical findings may include:

  • Low-grade fever
  • Beefy red tongue
  • Tachycardia
  • Blotchy skin pigmentation
  • Altered mental status
  • Visual deficits
  • Enlarged liver if heart failure is present

Initial lab tests include:

Complete blood count (CBC), serum B12 levels, and a peripheral smear. The CBC should demonstrate anemia, as shown by decreased hemoglobin and hematocrit (hemoglobin concentration less than 13 g/dL for men and less than 12 g/dL for women). The mean corpuscular volume (MCV) would be greater than or equal to 100 fL, an expected finding in macrocytic anemia. The peripheral blood smear may demonstrate hyper-segmented neutrophils (neutrophils with five lobes or greater). B12 levels of under 200 pg/mL are considered deficient. Indirect bilirubin and lactate dehydrogenase levels are usually elevated due to the rapid breakdown of red blood cells.

After initial lab tests confirm B12 deficiency, the diagnosis of pernicious anemia will depend on further testing, such as the presence of atrophic body gastritis (ABG) and intrinsic factor deficiency. One must rule out folic acid deficiency. Many patients with pernicious anemia will have elevated serum homocysteine and methylmalonic acid levels. Methylmalonic aciduria in the absence of an inborn error of methylmalonic acid metabolism confirms cobalamin deficiency. Diagnostic criteria for ABG require a histological sampling of gastric body mucosa. Findings associated with PA are the presence of corpus-restricted atrophy with a spared antrum, as well as the presence of hyperplasia of ECL cells. Serological markers can also help identify ABG; for example, increased levels of fasting gastrin and decreased levels of pepsinogen I suggest the presence of mucosal damage. Anti-intrinsic factor antibodies and anti-parietal cell antibodies should be evaluated in patients with a high probability of disease, even if B12 levels are normal. Some patients can have severe neurologic symptoms with falsely normal B12 levels.

Intrinsic factor deficiency can be evaluated by the Shilling test, which is now being replaced by other diagnostic strategies such as detecting intrinsic factor antibodies. Antibodies to intrinsic factor can be of two types. One is the blocking type against the B12 binding site present in 70% of patients, and the other is antibodies to parietal cells present in 90% of patients, but it is less specific.

Alternative and new approaches to the diagnosis of PA are under evaluation. One of these is a newer propriety cobalamin absorption test, which has its basis in measuring the change in holoTC following oral ingestion of non-radiolabeled cobalamin. Another approach has been described using accelerator mass spectrometry to quantify 14C in the blood following an orally administered dose of [14C]-cyanocobalamin. One may empirically administer vitamin B12 intramuscularly and assess the response if cobalamin deficiency is suspected. Most patients will feel clinically better within 24 hours. Additionally, marked reticulocytosis will appear within 5 to 7 days.

It is important to know that falsely low levels of cobalamin may occur in the following situations:

  • Multiple myeloma
  • Pregnancy
  • Use of hormonal therapy or oral contraceptives
  • Severe folic acid deficiency
  • High levels of ascorbic acid

Treatment

If pernicious anemia is ignored, undiagnosed, or left untreated, life-threatening complications can occur. Pernicious anemia is treated by the injection of vitamin B12 (hydroxocobalamin or cyanocobalamin) into the muscle. A physician must closely monitor the amount of vitamin that is given and adjust the dosage when necessary. People with pernicious anemia must continue to receive maintenance doses of vitamin B12 throughout life.

Patients generally receive an intramuscular injection of 1000 mcg B12 every day or every other day during the first week of treatment. The next month, they receive injections every week, subsequently followed by monthly injections. The alternative to intramuscular injection B12 is high-dose oral B12. A 1000 to 2000 mcg/day has been demonstrated to be effective, although recommendations are to always use the parenteral route in severe neurological manifestations. Approved sublingual and intranasal formulations of B12 are also available. Oral dosage is recommended for patients unable to take IM injections, but cobalamin levels must be measured frequently to ensure absorption. Finally, oral therapy is not recommended for patients with CNS symptoms.

Monitoring

The earliest sign of treatment response is an increase in reticulocyte count, usually within three days of treatment. Following changes in the decrease of biochemical markers such as MMA and plasma homocysteine levels have been observed in the first five days of treatment. Sustained normalization of serum cobalamin usually occurs following two weeks of therapy. The macrocytosis correction takes place during the first month of treatment. A clinical interview should be considered every year to monitor for new symptoms. These may include epigastric pain, dysphagia, iron deficiency, and/or others that can require gastroscopic investigation.

The key management principle is the importance of routine follow-up. Patients with underlying causes like chronic pancreatitis, bacterial overgrowth, or tapeworm will require additional treatments. Blood transfusions are not required in most patients. With treatment, the symptoms of heart failure resolve, but some patients may require concomitant diuretic therapy.

Genetic counseling may be of benefit for people with pernicious anemia and their families.

References

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Drink safe fluids and monitor temperature.
  • In dengue-prone areas, discuss CBC and platelet count when fever persists or warning signs appear.
  • Use tepid sponging for high fever discomfort; avoid ice-cold bathing.

OTC medicine safety

  • For fever, common fever medicine may be discussed with a clinician or pharmacist.
  • Avoid aspirin/ibuprofen-like medicines in suspected dengue unless a doctor says it is safe.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Fever with breathing difficulty, confusion, repeated vomiting, bleeding, severe weakness, stiff neck, or dehydration needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Medicine doctor / pediatrician for children / qualified clinician
Tests to discuss with doctor
  • Temperature chart and hydration assessment
  • CBC with platelet count if fever persists or dengue/other infection is possible
  • Urine test, malaria/dengue tests, chest evaluation, or blood culture only when clinically indicated
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?
  • Do I need antibiotics, or is this more likely viral?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Pernicious Anemia

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area from the RX Article Professional Blocks panel.

More from this topic
  1. Congenital Enterocyte Heparan Sulfate Deficiency

    DefinitionCongenital? enterocyte heparan sulfate deficiency is a very rare, severe, genetic intestinal disease. In this condition, the small bowel lining cells, called enterocytes, do not show...

    April 3, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  2. Congenital ectropion uveae

    DefinitionCongenital? ectropion uveae, often shortened to CEU, is a very rare eye condition present from birth. In this condition, the dark pigment layer that normally stays...

    April 2, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  3. Congenital Dyserythropoietic Anemia, Type III

    DefinitionCongenital? dyserythropoietic anemia?, type III, also called CDA type III, is a very rare inherited blood disease. In this disease, the bone marrow tries to make...

    April 2, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  4. Congenital Dyserythropoietic Anemia Type I

    DefinitionCongenital? dyserythropoietic anemia?, type I, usually called CDA type I, is a rare inherited blood disease. In this disease, the bone marrow tries to make red...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  5. Congenital Dyserythropoietic Anemia Due to KLF1 Mutation

    DefinitionCongenital? dyserythropoietic anemia? due to KLF1 mutation is a very rare inherited red blood cell disease. In most reported cases, doctors describe it as congenital? dyserythropoietic...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  6. Congenital Dyserythropoietic Anemia Due to KLF1 Mutation

    DefinitionCongenital? dyserythropoietic anemia? due to KLF1 mutation is a very rare inherited red blood cell disease. In most reported cases, doctors describe it as congenital? dyserythropoietic...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  7. HEMPAS – Hereditary Erythroblast Multinuclearity with Positive Acid Serum Test

    DefinitionHEMPAS – Hereditary Erythroblast Multinuclearity with Positive Acid Serum Test is a rare inherited blood disease. Its full old name is hereditary erythroblastic multinuclearity with positive...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  8. Congenital Dyserythropoietic Anemia Type 2

    DefinitionCongenital? dyserythropoietic anemia? type 2, also called CDA type II, is a rare inherited blood disease. In this disease, the body makes red blood cells in...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  9. Component of Oligomeric Golgi Complex 2–Congenital Disorder of Glycosylation

    DefinitionComponent of oligomeric Golgi complex 2–congenital? disorder of glycosylation is usually called COG2-CDG. It is a very rare inherited metabolic disease. In this disease, both copies...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)
  10. Congenital Disorder of Glycosylation, Type IIq

    DefinitionCongenital? disorder of glycosylation, type IIq, is a very rare inherited metabolic disease. It is now also commonly called COG2-CDG because it is caused by harmful...

    April 1, 2026 • Rx Autoimmune, Genetic and Rare Diseases (A - Z)